Data demonstrated a significantly positive association between CD44 expression level and stromal score, immune score, and ESTIMATE score according to the TCGA dataset (Figure 2A), indicating that changing stromal and infiltrating immune cells, CD44 can affect the glioma microenvironment. This evidence concerns the gene CD44 and glioma.